Design, Development and Evaluation of Erlotinib-Loaded Hybrid Nanoparticles for Targeted Drug Delivery to NonSmall Cell Lung Cancer | Zendy

AI Assistant Blog Pricing

Open Access

Design, Development and Evaluation of Erlotinib-Loaded Hybrid Nanoparticles for Targeted Drug Delivery to NonSmall Cell Lung Cancer

Author(s) -

Bivash Mandal

Publication year - 2015

Language(s) - English

Resource type - Dissertations/theses

DOI - 10.21007/etd.cghs.2015.0196

Subject(s) - erlotinib , epidermal growth factor receptor , drug delivery , pharmacology , chemistry , lung cancer , medicine , bovine serum albumin , epidermal growth factor , targeted drug delivery , cancer research , drug , cancer , receptor , biochemistry , organic chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Download on the

Discover

Explore

Copyright Knowledge E © 2026. All Rights Reserved.